heart lungs News
-
Lung Cancer Breath ‘Signature’ Presents Promise for Earlier Diagnosis
Founded in 1964, The Society of Thoracic Surgeons is a not-for-profit organization representing more than 7,200 cardiothoracic surgeons, researchers, and allied health care professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus, as well as other surgical procedures within the chest. The Society’s mission is to enhance ...
-
Deborah Heart and Lung Center Introduces the Ivenix Infusion System to the Hospital
Deborah Heart and Lung Center announces its successful hospital-wide go live with Ivenix, a modern smart infusion pump system. “Though everyone is familiar with IV pump delivery systems used to administer medications during a patient’s hospital stay, improvements in technology have allowed us to do it in a controlled and measured way,” said Rita Zenna, RN, Deborah’s Vice ...
By Ivenix, Inc.
-
N8 Medical Announces NHLBI Grant to Develop Antimicrobial Pacemaker Envelope
N8 Medical, LLC (N8 Medical) today announced that the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) indicated its intent to fund N8 Medical’s STTR Phase I grant application for the development of a resorbable envelope to prevent surgical site infections associated with pacemaker implantation surgeries. N8 Medical will be working with researchers ...
-
Coala introduces more advancements for the heart
Introducing the new Coala Monitoring Report – enhanced to provide physicians with a comprehensive summary of Coala generated data. The report is customizable and can be created on-demand at any time. An ideal tool to effectively track ECG and patient-reported symptoms, to support diagnosis, and document 30-day Event or long-term RPM billing. Coala is the ideal solution for long-term, ...
-
RURAL Cohort Study to Utilize PixCell Medical`s HemoScreen Hematology Analyzer for Research Initiative
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that the Risk Underlying Rural Areas Longitudinal Study (RURAL) has selected PixCell's novel miniaturized, portable hematology analyzer, HemoScreen™, as part of its six year research study, aiming to gain insight into the specific health-related concerns of the rural southeastern United States' ...
-
NIH statement on Asthma Awareness Month
For Asthma Awareness Month 2013, the National Institutes of Health stands with the international community to renew our dedication to improving the quality of life for the estimated 300 million people living with asthma worldwide. To most effectively manage asthma, we need to address the disproportionate impact of the disease on minorities and families at or below the poverty line. NIH is ...
-
EPA awards $160,000 to Boston public health commission to Aid Asthma Projects (MA)
EPA has awarded the Boston Public Health Commission a $160,000 grant todemonstrate the effectiveness of a citywide asthma intervention, providing home-based asthma education and environmental services by trained health workers. These services adhere to the National Heart, Lung Blood Institute guidance regarding the diagnosis and treatment of asthma and address multiple home environmental ...
-
Daxor Corporation Awarded Grant from the Center for Advancing Point of Care Technologies (Capcat) to Develop a Point-Of-Care Blood Volume Analyzer
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has been awarded a grant from the Center for Advancing Point of Care Technologies (CAPCaT), a program run by the Massachusetts Medical Device Development Center (M2D2) funded by the National Heart, Lung, and Blood Institute and the National Center for Complementary and Integrative ...
-
Vascugen Licenses Stem Cell Technology for Blood Vessel Regeneration Developed at IU School of Medicine
Vascuqen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University (IU) School of Medicine related to blood vessel formation from adult stem cells. The regenerative medicine company is focused on finding therapies to repair tissues damaged by reduced blood flow due to disease or injury. The worldwide, exclusive licenses include patent rights ...
-
Feldan therapeutics announces a publication in nature communications
In an article published in Nature Communications, entitled "Engineered Amphiphilic Peptides Enable Delivery of Proteins and CRISPR Associated Nucleases to Airway Epithelia” Dr. David Guay, Research Director of Feldan Therapeutics, and collaborator Dr. Paul McCray, from the University of Iowa Carver College of Medicine, demonstrate that Feldan’s engineered amphiphilic peptides (Feldan ...
-
Centerline Biomedical Awarded $1.5M Phase II NIH SBIR Grant to Advance Development of Next-Generation IOPS Technology
Centerline Biomedical, Inc. (Centerline) announced on April 21, 2020 the receipt of a Direct to Phase II Small Business Innovation Research (SBIR) grant award from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH). This represents the fourth small business grant awarded to the startup founded to commercialize and innovate IOPS™, a novel image guidance ...
-
BOHS cautions that new research into occupational exposure to diesel for professional drivers highlights a COVID-19 dilemma with ventilation
The British Occupational Hygiene Society, a scientific charity and the Chartered Society for Workplace Health Protection, is welcoming research published by Imperial College London’s DEMist project, which uses black carbon to track exposure of professional drivers to diesel exhaust. The study led by Dr Ian Mudway, Senior Lecturer at the MRC Centre for Environment and Health, Environmental ...
-
BOHS cautions that new research into occupational exposure to diesel for professional drivers highlights a COVID-19 dilemma with ventilation
BOHS welcomes new research by IOSH-sponsored Imperial College into occupational exposure to diesel for professional drivers, but cautions that it highlights a COVID-19 dilemma with ventilation. The British Occupational Hygiene Society, a scientific charity and the Chartered Society for Workplace Health Protection, is welcoming research published by Imperial College London’s ...
-
Discover our top-selling Precellys kits!
For many years, scientists all around the globe have been using Precellys lysing and grinding kits, as they have been proven efficient and safe in a broad range of research areas including microbiology, pharmacology, cancer, forensic medicine, the environment, and even agronomy. Here below, discover our top three bestselling kits and find the perfect solution for your sample prep! ...
-
National COPD Awareness Month and Identifying Airborne Exposure Risks in Puerto Rico
November is recognized as National COPD Awareness Month. The NIH’s National Heart, Lung, and Blood Institute states that it is a distinct time for the COPD community to come together with one voice to focus on increasing awareness of the disease. Across the nation, organizations are conducting outreach and holding events to bring greater visibility to COPD and to encourage people to ...
-
NuMedii Announces Creation of World’s First Single-Cell Sequencing Atlas for Idiopathic Pulmonary Fibrosis by its Collaborators
SAN MATEO, Calif., July 9, 2020 /PRNewswire/ — NuMedii, Inc., a data-driven drug discovery company, today announced the availability of the world’s first single-cell sequencing atlas for idiopathic pulmonary fibrosis (IPF) that was the result of a strategic research collaboration including the Yale School of Medicine, Baylor College of Medicine, Brigham and Women’s Hospital, and ...
-
Kardium’s Globe® System Begins Clinical Trial at St. Paul’s Hospital
VANCOUVER, British Columbia –?Kardium?Inc.?announces a successful first-in-BC investigational* clinical procedure using the Globe® Mapping and Ablation System. Dr. Marc Deyell of St. Paul’s Hospital leads the study using the Globe System to navigate inside the heart and diagnose where the rhythm disturbances occur. Once identified, the same device can then deliver immediate ...
By Kardium Inc.
-
Profusa, Inc. Receives CE Mark to Market the Lumee Oxygen Platform™ for Continuous, Real-time Monitoring of Tissue Oxygen
Profusa, Inc., a developer of tissue-integrated biosensors for continuous monitoring of body chemistry, today announced that it received the CE Mark to market its Lumee Oxygen Platform™ for continuous, real-time monitoring of tissue oxygen. The company will initially market the system for monitoring tissue oxygen in the treatment of peripheral artery disease (PAD). With an ...
-
The new Walloon company Cellaïon makes its first closing
Cellaïon, a Walloon biotechnology company created by a consortium of Belgian-Luxembourg investors, announces its first closing following the acquisition of the assets of Promethera and its HepaStem® technology platform. The consortium led by Fund Plus (Leuven, Belgium) is also composed of SMS Investments SA (Luxembourg), Sopartec (UCLouvain Technology Transfer Office, Louvain-la-Neuve, ...
By Cellaïon
-
A Complete Overview of a Life Saving Treatment - Liver Transplantation in India
Hepatic transplant or liver transplant is a treatment that includes the replacement of diseased liver with the healthy liver from another individual. It is a surgical treatment to remove the non-functional liver (liver failure) and replace it with the healthy liver (from a deceased donor) or a part of the healthy liver (from a living donor). Few important matters regarding liver transplantation ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you